These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36603162)

  • 21. Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia.
    Taslimi P; Aslan HE; Demir Y; Oztaskin N; Maraş A; Gulçin İ; Beydemir S; Goksu S
    Int J Biol Macromol; 2018 Nov; 119():857-863. PubMed ID: 30077669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies.
    Güleç Ö; Türkeş C; Arslan M; Demir Y; Dincer B; Ece A; İrfan Küfrevioğlu Ö; Beydemir Ş
    Bioorg Chem; 2024 Apr; 145():107221. PubMed ID: 38387398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pterin-7-carboxamides as a new class of aldose reductase inhibitors.
    Saito R; Suzuki S; Sasaki K
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4870-4874. PubMed ID: 27666634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
    Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
    Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors.
    Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM
    Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney.
    Demir Y; Işık M; Gülçin İ; Beydemir Ş
    J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28557170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
    Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
    Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
    Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity.
    Hlaváč M; Kováčiková L; Prnová MŠ; Šramel P; Addová G; Májeková M; Hanquet G; Boháč A; Štefek M
    J Med Chem; 2020 Jan; 63(1):369-381. PubMed ID: 31820975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles.
    Patnam N; Chevula K; Chennamsetti P; Aleti B; Kotha AK; Manga V
    Mol Divers; 2024 Jun; 28(3):1551-1563. PubMed ID: 37326778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and
    Hamdi A; Yaseen M; Ewes WA; Bhat MA; Ziedan NI; El-Shafey HW; Mohamed AAB; Elnagar MR; Haikal A; Othman DIA; Elgazar AA; Abusabaa AHA; Abdelrahman KS; Soltan OM; Elbadawi MM
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2231170. PubMed ID: 37470409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies.
    Bacha MM; Nadeem H; Zaib S; Sarwar S; Imran A; Rahman SU; Ali HS; Arif M; Iqbal J
    BMC Chem; 2021 Apr; 15(1):28. PubMed ID: 33906691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
    Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
    Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
    Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
    Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes.
    Demir Y; Köksal Z
    Arch Physiol Biochem; 2022 Aug; 128(4):979-984. PubMed ID: 32202954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Series of Isatin-Hydrazones with Cytotoxic Activity and CDK2 Kinase Inhibitory Activity: A Potential Type II ATP Competitive Inhibitor.
    Al-Salem HS; Arifuzzaman M; Alkahtani HM; Abdalla AN; Issa IS; Alqathama A; Albalawi FS; Rahman AFMM
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32992673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
    Gopinath G; Sankeshi V; Perugu S; Alaparthi MD; Bandaru S; Pasala VK; Chittineni PR; Krupadanam GLD; Sagurthi SR
    Eur J Med Chem; 2016 Nov; 124():750-762. PubMed ID: 27639366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats.
    Kumar MP; Sankeshi V; Naik RR; Thirupathi P; Das B; Raju TN
    Chem Biol Interact; 2015 Jul; 237():18-24. PubMed ID: 25986969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.